Lv1
90 积分 2023-11-21 加入
Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma
14小时前
待确认
The Effect of Postoperative TACE on Prognosis of HCC with Microscopic Venous Invasion
29天前
已关闭
Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial
1个月前
已完结
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
1个月前
已完结
Postoperative Lenvatinib plus PD-1 blockade reduces early tumor recurrence in hepatocellular carcinoma with MVI (BCLC 0-A): A Propensity Score Matching Analysis
2个月前
已完结
Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion
2个月前
已完结
A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma (HCC) who are at high risk of recurrence after curative hepatic resection
2个月前
已完结
Donafenib combined with anti-PD-1 antibody as adjuvant treatment in patients with hepatocellular carcinoma at high risk of recurrence after radical resection: A retrospective analysis
2个月前
已关闭
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2个月前
已完结
Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins
3个月前
已完结
皖公网安备34019202002308
